Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis

Pediatric Allergy and Immunology

Volumn 19, Issue 7, 2008, Pages 605-613

  Nakazato, Junko ^a   Kishida, Masaru ^a   Kuroiwa, Rei ^a   Fujiwara, Junko ^a   Shimoda, Makiko ^a   Shinomiya, Noriaki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

CCL27; Food allergy; Infantile atopic dermatitis; Scoring atopic dermatitis; Th2 chemokine

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; IMMUNOGLOBULIN E; MACROPHAGE DERIVED CHEMOKINE; OVALBUMIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; INFANT; INFANTILE ATOPIC DERMATITIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCORING ATOPIC DERMATITIS INDEX; SCORING SYSTEM; SKIN INFLAMMATION; TH2 CELL;

BIOLOGICAL MARKERS; CHEMOKINE CCL17; CHEMOKINE CCL22; CHEMOKINE CCL27; DERMATITIS, ATOPIC; FEMALE; HUMANS; INFANT; MALE; SEVERITY OF ILLNESS INDEX; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 54249129871     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00692.x     Document Type: Article

References (24)

1. Kouno Y. Epidemiology of atopic dermatitis. Jpn J Pediatrics 2006 : 59 : 1425 32.
2. Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004 : 113 : 925 31.
3. Pivarcsi A, Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep 2005 : 5 : 284 90.
4. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 : 113 : 651 7.
5. Sebastiani S, Denelon G, Gerber B, Uguccioni M. CCL22 induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of β strand of chemokine. Eur J Immunol 2005 : 35 : 746 56.
6. Hijnen D, de Bruin-Weller M, Oosting B, et al. Serum thymus and activation-regulated chemokine (CTACK) levels in allergic disease; TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004 : 113 : 334 40.
7. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczky A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005 : 60 : 685 8.
8. Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004 : 34 : 201 8.
9. Bordignon V, Sinagra JL, Trento E, et al. Antigen specific cytokine response in pediatric patients with atopic dermatitis. Pediatr Allergy Immunol 2005 : 16 : 113 20.
10. The Committee of the Japanese Dermatological Association: diagnostic criteria of atopic dermatitis. Jpn J Dermatol B 1994 : 104 : 1326.
11. Hanifin JM, Rajaka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980 : 92 (Suppl 44 7.
12. Kunz B, Oranje AP, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997 : 195 : 10 9.
13. Enrique E, Cistero-Bahima A. Specific immunotherapy for food allergy: basic principles and clinical aspects. Curr Opin Allergy Clin Immunol 2006 : 6 : 466 9.
14. Akids CA, Akids M, Trautmann A, Blaser K. Immune regulation in AD. Curr Opin Immunol 2000 : 12 : 641 8.
15. Leung TF, Ma KC, Hon KL, et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003 : 14 : 296 301.
16. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokine: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 2004 : 111 : 1185 99.
17. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin disease. J Dermatol Sci 2006 : 43 : 75 84.
18. Godiska R, Chantry D, Raport CJ, et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocytes derived dendritic cells, and natural killer cells. J Exp Med 1997 : 185 : 1595 604.
19. Hashimoto S, Nakamura K, Oyama N, et al. Macrophage-derived chemokine (MDC)/CCL22 producted by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci 2006 : 44 : 93 9.
20. Vestergaad C, Yoneyama H, Murai M, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999 : 104 : 1097 105.
21. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell mediated skin inflammation. Nat Med 2002 : 8 : 157 65.
22. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003 : 112 : 1195 202.
23. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999 : 96 : 14470 5.
24. Vestergaard C, Johansen C, Otkjaer K, Deleuran M, Iversen L. Tumor necrosis factor-α-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor κB. Cytokine 2005 : 29 : 49 55.